# Kroger Co: financial statements, quarterly

KR · NYSE · CIK 56873 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/kr.md) · [Financials](/companies/kr/financials.md) · [Filings](/companies/kr/filings.md) · [Insiders](/companies/kr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2022 (2022-11-05) | Q4 FY2022 (2023-01-28) | Q2 FY2023 (2023-08-12) | Q3 FY2023 (2023-11-04) | Q4 FY2023 (2024-02-03) | Q2 FY2024 (2024-08-17) | Q3 FY2024 (2024-11-09) | Q4 FY2024 (2025-02-01) | Q2 FY2025 (2025-08-16) | Q3 FY2025 (2025-11-08) | Q4 FY2025 (2026-01-31) | Q2 FY2026 (2026-08-15) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [34.2](/filings/0001558370-23-019686.md) | [34.8 d](/filings/0001558370-25-004267.md) | [33.9](/filings/0001558370-24-012921.md) | [34.0](/filings/0001558370-24-016233.md) | [37.1 d](/filings/0001104659-26-037723.md) | [33.9](/filings/0001104659-25-091648.md) | [33.6](/filings/0001104659-25-120642.md) | [34.3 d](/filings/0001104659-26-037723.md) | [33.9](/filings/0001104659-26-108926.md) | [33.9](/filings/0001104659-25-120642.md) | [34.7 d](/filings/0001104659-26-037723.md) | [34.6](/filings/0001104659-26-108926.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [0.8](/filings/0001558370-23-019686.md) | [0.8 d](/filings/0001558370-25-004267.md) | [(0.5)](/filings/0001558370-24-012921.md) | [0.9](/filings/0001558370-24-016233.md) | [1.2 d](/filings/0001104659-26-037723.md) | [0.8](/filings/0001104659-25-091648.md) | [0.8](/filings/0001104659-25-120642.md) | [0.9 d](/filings/0001104659-26-037723.md) | [0.9](/filings/0001104659-26-108926.md) | [(1.5)](/filings/0001104659-25-120642.md) | [1.2 d](/filings/0001104659-26-037723.md) | [1.0](/filings/0001104659-26-108926.md) |
| Interest expense | $bn | [0.1](/filings/0001558370-23-019686.md) | [0.1 d](/filings/0001558370-24-004603.md) | [0.1](/filings/0001558370-24-012921.md) | [0.1](/filings/0001558370-23-019686.md) | [0.1 d](/filings/0001558370-24-004603.md) | [0.1](/filings/0001558370-24-012921.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.1](/filings/0001558370-23-019686.md) | [0.2 d](/filings/0001558370-25-004267.md) | [(0.0)](/filings/0001558370-24-012921.md) | [0.2](/filings/0001558370-24-016233.md) | [0.2 d](/filings/0001104659-26-037723.md) | [0.1](/filings/0001104659-25-091648.md) | [0.2](/filings/0001104659-25-120642.md) | [0.1 d](/filings/0001104659-26-037723.md) | [0.2](/filings/0001104659-26-108926.md) | [(0.5)](/filings/0001104659-25-120642.md) | [0.3 d](/filings/0001104659-26-037723.md) | [0.2](/filings/0001104659-26-108926.md) |
| Net income | $bn | [0.4](/filings/0001558370-23-019686.md) | [0.5](/filings/0001558370-23-019686.md) | [(0.2)](/filings/0001558370-24-012921.md) | [0.6](/filings/0001558370-24-016233.md) | [0.7](/filings/0001558370-24-016233.md) | [0.5](/filings/0001104659-25-091648.md) | [0.6](/filings/0001104659-25-120642.md) | [0.6](/filings/0001104659-25-120642.md) | [0.6](/filings/0001104659-26-108926.md) | [(1.3)](/filings/0001104659-25-120642.md) | [0.9](/filings/0001104659-26-108926.md) | [0.6](/filings/0001104659-26-108926.md) |
| Diluted EPS | $ per share | [0.55](/filings/0001558370-23-019686.md) | not reported | [(0.25)](/filings/0001558370-24-012921.md) | [0.88](/filings/0001558370-24-016233.md) | not reported | [0.64](/filings/0001104659-25-091648.md) | [0.84](/filings/0001104659-25-120642.md) | not reported | [0.91](/filings/0001104659-26-108926.md) | [(2.02)](/filings/0001104659-25-120642.md) | not reported | [1.05](/filings/0001104659-26-108926.md) |
| Basic EPS | $ per share | [0.55](/filings/0001558370-23-019686.md) | not reported | [(0.25)](/filings/0001558370-24-012921.md) | [0.89](/filings/0001558370-24-016233.md) | not reported | [0.64](/filings/0001104659-25-091648.md) | [0.85](/filings/0001104659-25-120642.md) | not reported | [0.91](/filings/0001104659-26-108926.md) | [(2.02)](/filings/0001104659-25-120642.md) | not reported | [1.05](/filings/0001104659-26-108926.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-11-04) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-25) | Q2 FY2024 (2024-08-17) | Q3 FY2024 (2024-11-09) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-24) | Q2 FY2025 (2025-08-16) | Q3 FY2025 (2025-11-08) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-23) | Q2 FY2026 (2026-08-15) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.7](/filings/0001558370-23-019686.md) | [1.9](/filings/0001558370-25-004267.md) | [2.8](/filings/0001558370-24-009615.md) | [2.8](/filings/0001558370-24-012921.md) | [13.4](/filings/0001558370-24-016233.md) | [4.0](/filings/0001104659-26-037723.md) | [4.7](/filings/0001558370-25-008960.md) | [4.9](/filings/0001104659-25-091648.md) | [4.0](/filings/0001104659-25-120642.md) | [3.3](/filings/0001104659-26-108926.md) | [2.9](/filings/0001104659-26-078236.md) | [1.7](/filings/0001104659-26-108926.md) |
| Current assets | $bn | [13.4](/filings/0001558370-23-019686.md) | [12.9](/filings/0001558370-25-004267.md) | [14.2](/filings/0001558370-24-009615.md) | [14.1](/filings/0001558370-24-012921.md) | [25.0](/filings/0001558370-24-016233.md) | [15.3](/filings/0001104659-26-037723.md) | [15.8](/filings/0001558370-25-008960.md) | [15.8](/filings/0001104659-25-091648.md) | [16.0](/filings/0001104659-25-120642.md) | [14.5](/filings/0001104659-26-108926.md) | [14.2](/filings/0001104659-26-078236.md) | [12.9](/filings/0001104659-26-108926.md) |
| Total assets | $bn | [51.0](/filings/0001558370-23-019686.md) | [50.5](/filings/0001558370-25-004267.md) | [51.6](/filings/0001558370-24-009615.md) | [51.4](/filings/0001558370-24-012921.md) | [62.4](/filings/0001558370-24-016233.md) | [52.6](/filings/0001104659-26-037723.md) | [53.2](/filings/0001558370-25-008960.md) | [53.6](/filings/0001104659-25-091648.md) | [51.4](/filings/0001104659-25-120642.md) | [50.0](/filings/0001104659-26-108926.md) | [50.3](/filings/0001104659-26-078236.md) | [49.5](/filings/0001104659-26-108926.md) |
| Current liabilities | $bn | [16.8](/filings/0001558370-23-019686.md) | [16.1](/filings/0001558370-25-004267.md) | [16.4](/filings/0001558370-24-009615.md) | [16.1](/filings/0001558370-24-012921.md) | [16.3](/filings/0001558370-24-016233.md) | [15.9](/filings/0001104659-26-037723.md) | [16.6](/filings/0001558370-25-008960.md) | [16.7](/filings/0001104659-25-091648.md) | [18.2](/filings/0001104659-25-120642.md) | [18.1](/filings/0001104659-26-108926.md) | [18.0](/filings/0001104659-26-078236.md) | [18.4](/filings/0001104659-26-108926.md) |
| Total liabilities | $bn | [39.8](/filings/0001558370-23-019686.md) | [38.9](/filings/0001558370-25-004267.md) | [39.2](/filings/0001558370-24-009615.md) | [38.9](/filings/0001558370-24-012921.md) | [49.5](/filings/0001558370-24-016233.md) | [44.3](/filings/0001104659-26-037723.md) | [44.3](/filings/0001558370-25-008960.md) | [44.3](/filings/0001104659-25-091648.md) | [44.4](/filings/0001104659-25-120642.md) | [44.0](/filings/0001104659-26-108926.md) | [43.8](/filings/0001104659-26-078236.md) | [43.6](/filings/0001104659-26-108926.md) |
| Long-term debt | $bn | [10.1](/filings/0001558370-23-019686.md) | [10.2](/filings/0001558370-25-004267.md) | [10.2](/filings/0001558370-24-009615.md) | [10.2](/filings/0001558370-24-012921.md) | [20.6](/filings/0001558370-24-016233.md) | [15.8](/filings/0001104659-26-037723.md) | [15.3](/filings/0001558370-25-008960.md) | [15.3](/filings/0001104659-25-091648.md) | [14.5](/filings/0001104659-25-120642.md) | [14.5](/filings/0001104659-26-108926.md) | [14.5](/filings/0001104659-26-078236.md) | [13.9](/filings/0001104659-26-108926.md) |
| Current portion of debt | $bn | [0.6](/filings/0001558370-23-019686.md) | [0.0](/filings/0001558370-25-004267.md) | [0.0](/filings/0001558370-24-009615.md) | [0.0](/filings/0001558370-24-012921.md) | [0.0](/filings/0001558370-24-016233.md) | [0.1](/filings/0001104659-26-037723.md) | [0.6](/filings/0001558370-25-008960.md) | [0.6](/filings/0001104659-25-091648.md) | [1.4](/filings/0001104659-25-120642.md) | [1.4](/filings/0001104659-26-108926.md) | [0.9](/filings/0001104659-26-078236.md) | [1.5](/filings/0001104659-26-108926.md) |
| Shareholders' equity | $bn | [11.2](/filings/0001558370-23-019686.md) | [11.6](/filings/0001558370-25-004267.md) | [12.4](/filings/0001558370-24-009615.md) | [12.5](/filings/0001558370-24-012921.md) | [12.9](/filings/0001558370-24-016233.md) | [8.3](/filings/0001104659-26-037723.md) | [8.9](/filings/0001558370-25-008960.md) | [9.3](/filings/0001104659-25-091648.md) | [7.0](/filings/0001104659-25-120642.md) | [5.9](/filings/0001104659-26-108926.md) | [6.5](/filings/0001104659-26-078236.md) | [5.8](/filings/0001104659-26-108926.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2020 (2020-11-07) | Q4 FY2020 (2021-01-30) | Q3 FY2021 (2021-11-06) | Q4 FY2021 (2022-01-29) | Q3 FY2022 (2022-11-05) | Q4 FY2022 (2023-01-28) | Q3 FY2023 (2023-11-04) | Q4 FY2023 (2024-02-03) | Q3 FY2024 (2024-11-09) | Q4 FY2024 (2025-02-01) | Q3 FY2025 (2025-11-08) | Q4 FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [492 d](/filings/0001558370-21-016667.md) | [918 d](/filings/0001558370-23-004767.md) | [1,668 d](/filings/0001558370-22-018508.md) | [1,399 d](/filings/0001558370-24-004603.md) | [911 d](/filings/0001558370-23-019686.md) | [1,160 d](/filings/0001558370-25-004267.md) | [504 d](/filings/0001558370-24-016233.md) | [1,920 d](/filings/0001104659-26-037723.md) | [926 d](/filings/0001104659-25-120642.md) | [1,404 d](/filings/0001104659-26-037723.md) | [970 d](/filings/0001104659-25-120642.md) | [2,653 d](/filings/0001104659-26-037723.md) |
| Capital expenditure | $m | [719 d](/filings/0001558370-21-016667.md) | [803 d](/filings/0001558370-23-004767.md) | [689 d](/filings/0001558370-22-018508.md) | [606 d](/filings/0001558370-24-004603.md) | [831 d](/filings/0001558370-23-019686.md) | [817 d](/filings/0001558370-25-004267.md) | [953 d](/filings/0001558370-24-016233.md) | [997 d](/filings/0001104659-26-037723.md) | [954 d](/filings/0001104659-25-120642.md) | [884 d](/filings/0001104659-26-037723.md) | [941 d](/filings/0001104659-25-120642.md) | [946 d](/filings/0001104659-26-037723.md) |
| Dividends paid | $m | [141 d](/filings/0001558370-21-016667.md) | [139 d](/filings/0001558370-23-004767.md) | [159 d](/filings/0001558370-22-018508.md) | [156 d](/filings/0001558370-24-004603.md) | [187 d](/filings/0001558370-23-019686.md) | [188 d](/filings/0001558370-25-004267.md) | [210 d](/filings/0001558370-24-016233.md) | [210 d](/filings/0001104659-26-037723.md) | [231 d](/filings/0001104659-25-120642.md) | [232 d](/filings/0001104659-26-037723.md) | [237 d](/filings/0001104659-25-120642.md) | [226 d](/filings/0001104659-26-037723.md) |
| Share repurchases | $m | [320 d](/filings/0001558370-21-016667.md) | [335 d](/filings/0001558370-23-004767.md) | [298 d](/filings/0001558370-22-018508.md) | [598 d](/filings/0001558370-24-004603.md) | [10.0 d](/filings/0001558370-23-019686.md) | [8.0 d](/filings/0001558370-25-004267.md) | [7.0 d](/filings/0001558370-24-016233.md) | [8.0 d](/filings/0001104659-26-037723.md) | [9.0 d](/filings/0001104659-25-120642.md) | [4,031 d](/filings/0001104659-26-037723.md) | [738 d](/filings/0001104659-25-120642.md) | [1,758 d](/filings/0001104659-26-037723.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2020 (2021-01-30) | Q2 FY2021 (2021-08-14) | Q3 FY2021 (2021-11-06) | Q2 FY2022 (2022-08-13) | Q3 FY2022 (2022-11-05) | Q2 FY2023 (2023-08-12) | Q3 FY2023 (2023-11-04) | Q2 FY2024 (2024-08-17) | Q3 FY2024 (2024-11-09) | Q2 FY2025 (2025-08-16) | Q3 FY2025 (2025-11-08) | Q2 FY2026 (2026-08-15) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [761](/filings/0001558370-21-003706.md) | [755](/filings/0001558370-22-014443.md) | [752](/filings/0001558370-22-018508.md) | [725](/filings/0001558370-23-015803.md) | [724](/filings/0001558370-23-019686.md) | [719](/filings/0001558370-24-012921.md) | [725](/filings/0001558370-24-016233.md) | [727](/filings/0001104659-25-091648.md) | [728](/filings/0001104659-25-120642.md) | [665](/filings/0001104659-26-108926.md) | [655](/filings/0001104659-25-120642.md) | [608](/filings/0001104659-26-108926.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 590,588,700 at 2026-09-15, from the cover of the [10-Q filed 2026-09-18](/filings/0001104659-26-108926.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.